Evidence map›Paper›PMID 36695437›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2023

Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkers.

Haiyan Liu, Nicolas R Barthélemy, Vitaliy Ovod, James G Bollinger, Yingxin He, Samir L Chahin, Brendan Androff, Randall J Bateman, Brendan P Lucey

Open access · greenAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. A gradual and sustainable approach to diagnosing sleep and circadian disturbances in dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  15. Article
  16. Wake-promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Haiyan LiuDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Nicolas R BarthélemyDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Vitaliy OvodDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
James G BollingerDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Yingxin HeDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Samir L ChahinDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Brendan AndroffDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Randall J BatemanDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Brendan P LuceyDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
Washington University in St. Louis · USSt. Louis University High School · US

Funding

WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI FAGAN, ANNE · 1985 to 2019
$52.1M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI DAVID M. HOLTZMAN · 2020 to 2026
$28.7M
Protein Aggregation and Neurotransmitter Deficits in Parkinson DiseaseR01NS097799 · NINDS · WASHINGTON UNIVERSITY · PI PAUL T KOTZBAUER · 2016 to 2026
$5.8M
CNS and Plasma Amyloid--Beta Kinetics in Alzheimer's DiseaseR01NS065667 · NINDS · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2008 to 2016
$4.6M
SLEEP QUALITY AND HUMAN AMLYOID-BETA KINETICSK76AG054863 · NIA · WASHINGTON UNIVERSITY · PI LUCEY, BRENDAN PATRICK · 2016 to 2020
$982k
SLEEP: A POTENTIAL NOVEL MODULATOR OF ALZHEIMER'S DISEASE PATHOLOGYR03AG047999 · NIA · WASHINGTON UNIVERSITY · PI LUCEY, BRENDAN PATRICK · 2014 to 2015
$225k
NIA NIH HHS K76 AG054863NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS P50 AG005681NIA NIH HHS R03 AG047999NINDS NIH HHS R01 NS065667NINDS NIH HHS R01 NS097799
6 · The paper itself

Abstract

introductionSleep deprivation increases cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau levels; however, sleep's effect on Aβ and tau in plasma is unknown.

methodsIn a cross-over design, CSF Aβ and tau concentrations were measured in five cognitively normal individuals who had blood and CSF collected every 2 hours for 36 hours during sleep-deprived and normal sleep control conditions.

resultsAβ40, Aβ42, unphosphorylated tau threonine181 (T181), unphosphorylated tau threonine-217 (T217), and phosphorylated T181 (pT181) concentrations increased ∼35% to 55% in CSF and decreased ∼5% to 15% in plasma during sleep deprivation. CSF/plasma ratios of all Alzheimer's disease (AD) biomarkers increased during sleep deprivation while the CSF/plasma albumin ratio, a measure of blood-CSF barrier permeability, decreased. CSF and plasma Aβ42/40, pT181/T181, and pT181/Aβ42 ratios were stable longitudinally in both groups. DISCUSSION: These findings show that sleep loss alters some plasma AD biomarkers by lowering brain clearance mechanisms and needs to be taken into account when interpreting individual plasma AD biomarkers but not ratios.

Indexed as

Alzheimer DiseaseSleep Initiation and Maintenance DisordersSleep Wake DisordersAmyloid beta-PeptidesBiomarkersHumansPeptide FragmentsSleepSleep Deprivationtau ProteinsAmyloid beta-PeptidesBiomarkersPeptide Fragmentstau ProteinsAlzheimer's diseasebiomarkerssleep

Identifiers

PMID36695437
PMCPMC10366339
OpenAlexW4317936552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.